Furuichi Kengo, Wada Takashi, Kitajikma Shinji, Toyama Tadasi, Okumura Toshiya, Hara Akinori, Kawachi Hiroshi, Shimizu Fujio, Sugaya Takeshi, Mukaida Naofumi, Narumi Shosaku, Matsushima Kouji, Kaneko Shuichi
Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
Nephron Exp Nephrol. 2008;109(1):c29-38. doi: 10.1159/000135675. Epub 2008 Jun 3.
Although renal tubular cell proliferation after acute tubular necrosis is an important and essential response in the recovery of renal dysfunction in acute renal failure, the precise factors and mechanisms of tubular cell regeneration remain unclear. Here, we describe our studies using a neutralizing antibody (Ab) against interferon-inducible protein of 10 kDa (IP-10; CXCL10) that indicate a role for CXCL10 in tubular cell proliferation after renal ischemia-reperfusion injury. Tissue necrosis and interstitial infiltrating numbers were comparable between anti-CXCL10 Ab-treated and control mice treated with IgG at the 24 and 48 h time points after reperfusion. In contrast, the numbers of Ki67-positive proliferating tubular cells were significantly increased in anti-CXCL10 Ab-treated mice 48 h after reperfusion. In accordance with the in vivo findings,in vitro studies using murine tubular epithelial cells indicated an antiproliferative effect of CXCL10 upon the intensity of cell proliferation and the number of Ki67-positive cells. These data suggest that CXCL10 plays a role in the regulation of tubular cell proliferation following renal ischemia-reperfusion injury.
尽管急性肾小管坏死之后肾小管细胞增殖是急性肾衰竭肾功能恢复过程中的一种重要且必要的反应,但肾小管细胞再生的确切因素和机制仍不清楚。在此,我们描述了我们使用针对10 kDa干扰素诱导蛋白(IP-10;CXCL10)的中和抗体(Ab)所做的研究,这些研究表明CXCL10在肾缺血再灌注损伤后的肾小管细胞增殖中发挥作用。在再灌注后24小时和48小时的时间点,抗CXCL10抗体处理的小鼠与用IgG处理的对照小鼠之间的组织坏死和间质浸润数量相当。相比之下,再灌注后48小时,抗CXCL10抗体处理的小鼠中Ki67阳性的增殖肾小管细胞数量显著增加。与体内研究结果一致,使用小鼠肾小管上皮细胞的体外研究表明CXCL10对细胞增殖强度和Ki67阳性细胞数量具有抗增殖作用。这些数据表明CXCL10在肾缺血再灌注损伤后肾小管细胞增殖的调节中发挥作用。